Management Team
CEO
Damien Hancox
Damien Hancox is a seasoned professional with a diverse background spanning technology, innovation, and business strategy. Known for his ability to bridge the gap between technical execution and visionary leadership, Damien has led initiatives that drive meaningful impact across startups and established enterprises alike.
With a deep passion for emerging technologies and a track record of delivering results, Damien excels in dynamic environments where creativity and precision are both essential. His work often centers on applying advanced solutions to real-world challenges, fostering cross-functional collaboration, and mentoring teams to exceed ambitious goals.
In addition to his professional endeavors, Damien is an avid learner and competitor, known for balancing strategic focus with hands-on execution. Whether working on complex projects, engaging with industry peers, or navigating high-stakes scenarios, he brings clarity, commitment, and energy to every endeavor.
CFO
Barry Saint
A Cambridge University Engineering graduate, Barry has over 20 years’ experience as a FTSE-250 global finance and strategy leader. Additionally he is a seasoned investment banker. Extensively experienced at raising capital for growth companies, including at IPO and from venture/private equity sources, he has also worked with company boards and backers to source and secure value-accretive collaborations and M&A, often internationally.
He has served as CFO of an early stage biotechnology company and as Group Treasurer of a $1 billion revenue pharmaceutical business, Indivior. He has built and led high performing finance and multi-disciplinary teams servicing operations in over 40 countries. In the US, he acquired substantial healthcare industry experience. He oversaw the upgrading of financial reporting processes, controls and led collaborations enabling significant growth.
Barry commenced his advisory career as a strategy consultant with KPMG, before moving into investment banking with Dresdner Kleinwort.
NON-EXECUTIVE DIRECTOR, AUDIT COMMITTEE CHAIR
Debra Leeves
Debra has worked in technology companies and the pharmaceutical industry for the past 25 years, leading companies in the US, Asia-Pac, and Europe. During her career she has held various senior and C-level positions both in start-ups and large multinationals, including Pfizer, GSK, and GE. Her experience spans both business and clinical roles including sales, marketing, finance, quality, and medical affairs.
She is currently CEO for Vertual Ltd, a leading global supplier of virtual reality (VR) training systems, and prior to that was CEO for Physeon GmbH, and Managing Director for Avita Medical Ltd.
She has held public and listed company board roles and is currently Chair of Atelerix, Chair of the Institute of Directors (East Yorkshire), Non-Executive Director of Cambridge Cognition, and is the commercial champion and mentor for several university spinouts. She has a degree in Pharmacy, an MBA from Warwick Business school and is a part qualified Management Accountant (CIMA).
OPERATIONS DIRECTOR
Ben Hibbert
Ben has been with the organisation from the beginning and heads up operational functions leading key business projects from inception to successful completion. The knowledge gained from his involvement in all aspects of operations is used in making/executing sound strategic decisions to progress the business.
With a background as a chartered surveyor of over two decades delivering complex schemes around the UK in sectors including manufacturing, research, logistics, education and health, Ben has fine-tuned the art of taking a project from inception to delivery and believes that strong relationships and managing communication between all parties sit at the heart of successful implementation.
Outside of work, Ben enjoys spending time with his young family and running.
MARKETING DIRECTOR
Jennifer Von Strohe
Jennifer Von Strohe is an accomplished marketing executive with over 25 years of global experience shaping brand strategy, driving commercial growth, and leading high-impact marketing initiatives across biotech, fintech, FMCG, and gaming industries.
Her career spans leadership roles where she has built and transformed brands, led digital and product innovation, and directed integrated campaigns that fuel business performance. With deep expertise across marketing, public relations, customer experience, and product development, Jennifer is known for delivering scalable solutions that connect strategy to execution.
She has worked with a range of organisations—from high-growth start-ups to public companies—guiding them through market expansion, repositioning efforts, and funding milestones. Her approach blends data-driven decision-making with creative insight, enabling brands to grow sustainably while remaining adaptable in fast-moving markets.
Currently serving as Acting Marketing Director at SpectrumX, Jennifer was one of the founding team members and has played an integral role in the company’s development and expansion. She leads strategic marketing efforts to support SpectrumX’s innovation in the healthcare and life sciences space. Jennifer holds a double major in Marketing and Management with a minor in Psychology and is based in Greater London, UK.
QUALITY DIRECTOR
Omair Sattar
With over a decade of experience in pharmaceutical quality, Omair Sattar has built a strong track record across sterile, non-sterile, and GMP-regulated environments. As Quality Director at SpectrumX, he leads strategic quality initiatives, regulatory compliance, and operational excellence across the organisation.
He has successfully led Quality Assurance, Quality Control, and R&D teams in both clinical and commercial settings, with expertise spanning regulatory inspections, QMS implementation, batch release, deviation management, and supplier qualification.
His background includes clinical research, pharmaceutical manufacturing, and the importation of cannabis-based medicinal products. As a Responsible Person (RP) on multiple MHRA licences—including MIA(IMP), MS, and WDA(H)—he ensures that all products and processes meet the highest standards of patient safety and regulatory compliance. Committed to continuous improvement, he consistently upholds robust, inspection-ready quality systems that foster innovation and trust.
GENERAL MANAGER
Richard Jones
About Us
SpectrumX is a biotechnology company focused on providing safe and effective healthcare products powered by proprietary HOCI formulations.
SpectrumX is the ONLY company in the UK and Europe to have the license to use the patented, shielded HOCl+ Plus formulation, Spectricept™.
HEAD OF CLINICAL DEVELOPMENT
Leah Heathman
A senior Regulatory Affairs professional with 15 years’ experience across a broad range of therapeutic areas within leading pharmaceutical companies. Extensive knowledge of regulatory procedures ensuring successful registration and maintenance within the EU and RoW. A strong leader competent in line-management, ensuring productive and happy teams and experienced in setting up Regulatory systems/processes, writing SOPs and training.
An effective communicator delivering regulatory strategy and engaging with cross-functional teams and global Health Authorities. A Green Belt in Lean Six Sigma with proven project management skills and a drive for achieving project objectives with a clear focus on compliance and commercial timelines. Recently appointed as a member of the MHRA Review Panel.
